{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T01:15:45Z","timestamp":1795137345441,"version":"4.10.3"},"reference-count":73,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,10,7]],"date-time":"2027-10-07T00:00:00Z","timestamp":1822867200000},"content-version":"am","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100002894","name":"AAAAI Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002894","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002567","name":"American Academy of Allergy Asthma and Immunology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002567","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["K23AI163350"],"award-info":[{"award-number":["K23AI163350"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jaip.2026.06.023","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:40:12Z","timestamp":1782258012000},"page":"2237-2243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Quality and Safety Intervention: Improving Care of Patients Undergoing B Cell\u2013Targeted Therapies"],"prefix":"10.1016","volume":"14","author":[{"given":"Iris","family":"Otani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxane","family":"Labrosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel V.","family":"DiGiacomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Barmettler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2026.06.023_bib1","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1093\/rheumatology\/ket445","article-title":"BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis","volume":"53","author":"Ntatsaki","year":"2014","journal-title":"Rheumatology"},{"issue":"3 suppl","key":"10.1016\/j.jaip.2026.06.023_bib2","first-page":"S71","article-title":"KDIGO 2024 clinical practice guideline for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.jaip.2026.06.023_bib3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0140-6736(23)01736-1","article-title":"Diagnosis and management of ANCA-associated vasculitis","volume":"403","author":"Kronbichler","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2026.06.023_bib4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/rheumatology\/kex286","article-title":"The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults","volume":"57","author":"Gordon","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaip.2026.06.023_bib5","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/ard.2010.144998","article-title":"Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis","volume":"70","author":"Buch","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2026.06.023_bib6","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1093\/rheumatology\/ker106a","article-title":"BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis","volume":"50","author":"Bukhari","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaip.2026.06.023_bib7","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.jaci.2022.01.025","article-title":"Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: a work group report of the AAAAI Primary Immunodeficiency and Altered Immune Response Committees","volume":"149","author":"Otani","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.06.023_bib8","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/art.41773","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaip.2026.06.023_bib9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/MOP.0000000000001396","article-title":"Secondary hypogammaglobulinemia: diagnosis and management of a pediatric condition of clinical importance","volume":"36","author":"DiGiacomo","year":"2024","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.jaip.2026.06.023_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1497921","article-title":"Unmasking inborn errors of immunity: identifying the red flags of immune dysregulation","volume":"15","author":"Cortesi","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.06.023_bib11","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/hematology.2020000173","article-title":"How to evaluate for immunodeficiency in patients with autoimmune cytopenias: laboratory evaluation for the diagnosis of inborn errors of immunity associated with immune dysregulation","volume":"2020","author":"Abraham","year":"2020","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jaip.2026.06.023_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaip.2019.07.032","article-title":"Rituximab unveils hypogammaglobulinemia and immunodeficiency in children with autoimmune cytopenia","volume":"8","author":"Ottaviano","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.06.023_bib13","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jaci.2016.12.978","article-title":"Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies","volume":"140","author":"Fischer","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.06.023_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.649182","article-title":"Primary immunodeficiency in children with autoimmune cytopenias: retrospective 154-patient cohort","volume":"12","author":"Westermann-Clark","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.06.023_bib15","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.anai.2025.10.026","volume":"136","author":"Orange","year":"2026","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2026.06.023_bib16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaci.2024.11.026","article-title":"Therapeutic B-cell depletion: mechanisms, clinical applications, and implications for secondary immunodeficiency","volume":"156","author":"Elmoursi","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.06.023_bib17","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jaip.2024.12.024","article-title":"If and when to consider prophylactic immunoglobulin replacement therapy in secondary hypogammaglobulinemia","volume":"13","author":"Otani","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.06.023_bib18","doi-asserted-by":"crossref","DOI":"10.70962\/jhi.20250002","article-title":"The 2024 update of IUIS phenotypic classification of human inborn errors of immunity","volume":"1","author":"Bousfiha","year":"2025","journal-title":"J Hum Immun"},{"key":"10.1016\/j.jaip.2026.06.023_bib19","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMra2033982","article-title":"Autoimmune hemolytic anemias","volume":"385","author":"Berentsen","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.06.023_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.911385","article-title":"Targeted treatment of autoimmune cytopenias in primary immunodeficiencies","volume":"13","author":"Pacillo","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.06.023_bib21","article-title":"Autoimmune cytopenias and dysregulated immunophenotype act as warning signs of inborn errors of immunity: results from a prospective study","volume":"12","author":"Schiavo","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.06.023_bib22","article-title":"Investigating biomarkers for inborn errors of immunity in a prospective study of patients with autoimmune cytopenia","volume":"73","author":"Ga\u00e1l","year":"2026","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jaip.2026.06.023_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1182\/hematology.2024000538","article-title":"Common variable immunodeficiency: autoimmune cytopenias and advances in molecular diagnosis","volume":"2024","author":"Cunningham-Rundles","year":"2024","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jaip.2026.06.023_bib24","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(23)02705-8","article-title":"B-cell non-Hodgkin lymphomas","volume":"403","author":"Silkenstedt","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2026.06.023_bib25","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMra1702693","article-title":"Post-transplantation lymphoproliferative disorders in adults","volume":"378","author":"Dierickx","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.06.023_bib26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/10428194.2019.1672056","article-title":"Primary immunodeficiencies and lymphoma: a systematic review of literature","volume":"61","author":"Herber","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jaip.2026.06.023_bib27","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3389\/fimmu.2018.01103","article-title":"Inherited immunodeficiencies with high predisposition to Epstein-Barr virus-driven lymphoproliferative diseases","volume":"9","author":"Latour","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.06.023_bib28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cmi.2022.10.003","article-title":"When to suspect inborn errors of immunity in Epstein-Barr virus-related lymphoproliferative disorders","volume":"29","author":"Sacco","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jaip.2026.06.023_bib29","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1097\/MPH.0000000000002817","article-title":"Malignancies and lymphoproliferations in children with primary immune deficiency-a single-center experience","volume":"46","author":"Aydogmus","year":"2024","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jaip.2026.06.023_bib30","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10875-016-0324-z","article-title":"Lymphoma secondary to congenital and acquired immunodeficiency syndromes at a Turkish pediatric oncology center","volume":"36","author":"Tanyildiz","year":"2016","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaip.2026.06.023_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.110269","article-title":"Clinical features and lymphocyte immunophenotyping analysis in primary immunodeficiency patients with non-transplant lymphoproliferative disorders","volume":"265","author":"Lee","year":"2024","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2026.06.023_bib32","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1016\/S2352-3026(23)00362-9","article-title":"Diagnostic evaluation of paediatric autoimmune lymphoproliferative immunodeficiencies (ALPID): a prospective cohort study","volume":"11","author":"H\u00e4gele","year":"2024","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jaip.2026.06.023_bib33","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1007\/s00277-025-06456-1","article-title":"Inborn errors of immunity presenting with lymphoproliferation: lessons from a case series","volume":"104","author":"Costagliola","year":"2025","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jaip.2026.06.023_bib34","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/acr.25348","article-title":"2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) guideline for the treatment of interstitial lung disease in people with systemic autoimmune rheumatic diseases","volume":"76","author":"Johnson","year":"2024","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jaip.2026.06.023_bib35","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s10875-023-01552-1","article-title":"Common and uncommon CT findings in CVID-related GL-ILD: correlations with clinical parameters, therapeutic decisions and potential implications in the differential diagnosis","volume":"43","author":"Scarpa","year":"2023","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaip.2026.06.023_bib36","article-title":"Genetics and clinical phenotypes in common variable immunodeficiency","volume":"14","author":"Cunningham-Rundles","year":"2023","journal-title":"Front Genet"},{"key":"10.1016\/j.jaip.2026.06.023_bib37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/cei.13600","article-title":"Comprehensive comparison between 222 CTLA-4 haploinsufficiency and 212 LRBA deficiency patients: a systematic review","volume":"205","author":"Jamee","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2026.06.023_bib38","article-title":"STAT3 gain-of-function syndrome","volume":"10","author":"Vogel","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaip.2026.06.023_bib39","article-title":"An AIREless breath: pneumonitis caused by impaired central immune tolerance","volume":"11","author":"Ferr\u00e9","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.06.023_bib40","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.rdc.2023.06.005","article-title":"COPA syndrome from diagnosis to treatment: a clinician\u2019s guide","volume":"49","author":"Simchoni","year":"2023","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jaip.2026.06.023_bib41","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1164\/rccm.201510-2102LE","article-title":"Interstitial lung disease caused by STING-associated vasculopathy with onset in infancy","volume":"194","author":"Clarke","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.06.023_bib42","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/acr.22246","article-title":"Effect of methotrexate, anti-tumor necrosis factor \u03b1, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"66","author":"Hua","year":"2014","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jaip.2026.06.023_bib43","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/ene.12132","article-title":"Reduced antibody formation after influenza vaccination in patients with neuromyelitis optica spectrum disorder treated with rituximab","volume":"20","author":"Kim","year":"2013","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jaip.2026.06.023_bib44","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/art.25034","article-title":"Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial","volume":"62","author":"Bingham","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaip.2026.06.023_bib45","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/art.25033","article-title":"Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab","volume":"62","author":"van Assen","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"3 suppl","key":"10.1016\/j.jaip.2026.06.023_bib46","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2016.09.023","article-title":"Update on the use of immunoglobulin in human disease: a review of evidence","volume":"139","author":"Perez","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.06.023_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clim.2010.06.012","article-title":"Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies","volume":"137","author":"Orange","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2026.06.023_bib49","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3324\/haematol.2013.101261","article-title":"Subcutaneous immunoglobulin in lymphoproliferative disorders and rituximab-related secondary hypogammaglobulinemia: a single-center experience in 61 patients","volume":"99","author":"Compagno","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.jaip.2026.06.023_bib50","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/bjh.18075","article-title":"Guideline for the treatment of chronic lymphocytic leukaemia","volume":"197","author":"Walewska","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaip.2026.06.023_bib51","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.annonc.2021.12.003","volume":"33","author":"Hayden","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaip.2026.06.023_bib52","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jaci.2015.06.035","article-title":"Continuing IgG replacement therapy for hypogammaglobulinemia after rituximab--for how long?","volume":"136","author":"Barmettler","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.06.023_bib53","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.iac.2008.06.006","article-title":"Pharmacokinetics of immunoglobulin administered via intravenous or subcutaneous routes","volume":"28","author":"Bonilla","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2026.06.023_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31779","article-title":"Hypogammaglobulinemia in children receiving targeted immunotherapies for B lineage malignancies: practical guidance for assessment and management","volume":"72","author":"Long","year":"2025","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jaip.2026.06.023_bib55","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/j.jaci.2018.02.017","article-title":"Age-associated distribution of normal B-cell and plasma cell subsets in peripheral blood","volume":"141","author":"Blanco","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.06.023_bib56","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/17474086.2022.2063833","article-title":"Managing hypogammaglobulinemia in patients treated with CAR-T-cell therapy: key points for clinicians","volume":"15","author":"Kampouri","year":"2022","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.jaip.2026.06.023_bib57","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jaci.2021.03.041","article-title":"Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patients","volume":"148","author":"Labrosse","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.06.023_bib58","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12969-019-0365-y","article-title":"Rituximab-associated hypogammaglobulinemia in pediatric patients with autoimmune diseases","volume":"17","author":"Khojah","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.jaip.2026.06.023_bib59","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.12998\/wjcc.v7.i9.1021","article-title":"Rituximab-induced IgG hypogammaglobulinemia in children with nephrotic syndrome and normal pre-treatment IgG values","volume":"7","author":"Marzuillo","year":"2019","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.jaip.2026.06.023_bib60","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1200\/JCO.22.00642","article-title":"Three-year update of tisagenlecleucel in pediatric and young adult patients with relapsed\/refractory acute lymphoblastic leukemia in the ELIANA trial","volume":"41","author":"Laetsch","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaip.2026.06.023_bib61","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.anai.2023.01.018","article-title":"Hypogammaglobulinemia, late-onset neutropenia, and infections following rituximab","volume":"130","author":"Athni","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2026.06.023_bib62","doi-asserted-by":"crossref","DOI":"10.70962\/jhi.20250003","article-title":"Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee","volume":"1","author":"Poli","year":"2025","journal-title":"J Hum Immun"},{"key":"10.1016\/j.jaip.2026.06.023_bib63","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jaci.2021.04.015","article-title":"Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations","volume":"148","author":"Thalhammer","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.06.023_bib64","doi-asserted-by":"crossref","DOI":"10.70962\/jhi.20250007","article-title":"Inborn errors of immunity: manifestation, treatment, and outcome-an ESID registry 1994-2024 report on 30,628 patients","volume":"1","author":"Kindle","year":"2025","journal-title":"J Hum Immun"},{"key":"10.1016\/j.jaip.2026.06.023_bib65","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2018-11-887141","article-title":"Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes","volume":"134","author":"Hadjadj","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2026.06.023_bib66","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/bjh.19073","article-title":"Paediatric-onset Evans syndrome: breaking away from refractory immune thrombocytopenia","volume":"203","author":"Aladjidi","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaip.2026.06.023_bib67","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.jaci.2024.01.011","article-title":"Validating inborn error of immunity prevalence and risk with nationally representative electronic health record data","volume":"153","author":"Rider","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.06.023_bib68","article-title":"Clinical courses of IKAROS and CTLA4 deficiencies: a systematic literature review and retrospective longitudinal study","volume":"12","author":"Hoshino","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.06.023_bib69","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00467-022-05739-3","article-title":"IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome","volume":"38","author":"Trautmann","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jaip.2026.06.023_bib70","article-title":"Utility of serum cytokine testing to differentiate complicated common variable immunodeficiency in resource limited settings","volume":"4","author":"Jogdand","year":"2025","journal-title":"J Allergy Clin Immunol Glob"},{"key":"10.1016\/j.jaip.2026.06.023_bib71","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaci.2021.04.039","article-title":"Therapeutic options for CTLA-4 insufficiency","volume":"149","author":"Egg","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.06.023_bib72","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.anai.2024.11.018","article-title":"Targeted treatment for activated phosphoinositide 3-kinase delta syndrome, CTLA-4 insufficiency, and STAT1 gain-of-function","volume":"134","author":"Saff","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2026.06.023_bib73","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1182\/bloodadvances.2023011000","article-title":"Long-term treatment with selective PI3K\u03b4 inhibitor leniolisib in adults with activated PI3K\u03b4 syndrome","volume":"8","author":"Rao","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaip.2026.06.023_bib74","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jaci.2023.10.018","article-title":"JAK inhibitor treatment for inborn errors of JAK\/STAT signaling: an ESID\/EBMT-IEWP retrospective study","volume":"153","author":"Fischer","year":"2024","journal-title":"J Allergy Clin Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826005179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826005179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T00:29:35Z","timestamp":1795134575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219826005179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":73,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2213219826005179"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2026.06.023","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality and Safety Intervention: Improving Care of Patients Undergoing B Cell\u2013Targeted Therapies","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2026.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}